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 Abstract 
Adrenomedullin (AM) is a multifunctional regulatory peptide with important angiogenic and 
mitogenic properties. Here we identify a region of stable secondary structure in the 5’-
untranslated region (5’ UTR) of human AM mRNA. Reverse transcriptase polymerase chain 
reaction of the 5’ UTR consistently resulted, in addition to the product with the expected size 
of 155 base-pair (bp), in a second product with a ~65-bp deletion from the central region of 
the 5’ UTR, suggesting the presence of a secondary structure. The presence of a stem-loop 
structure was confirmed by probing the 5’ UTR with RNases with selectivity for single- or 
double-stranded RNA. We investigated the role of this stem-loop structure in expression of 
luciferase reporter gene in cultured cell lines. Reporter assays using a chimeric mRNA that 
combined luciferase and the 5’ UTR of AM mRNA demonstrated a dramatic decrease of the 
reporter activity due to a decreased translation, while the deletion of the stem-loop structure 
localized between nt +31 to +95 from the cap site led to the recovery of activity. Gel migration 
shift assays using cytosolic extracts from mammalian cell lines demonstrate a specific binding 
of a cytosolic protein to riboprobes containing the 5’ UTR of AM but not to riboprobes either 
corresponding to other areas of the message or containing the 5’ UTR but lacking the region 
of secondary structure. Although we conclude that the 5’ UTR of the human AM mRNA can 
modulate the translation of AM mRNA in vivo, and that the predicted stem-loop structure is 
necessary for this inhibition, the functional consequences of the cis element-binding activity 
remain to be determined.  
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 Introduction 
 The translational control of specific mRNAs is a prominent mechanism of gene 
regulation contributing to diverse physiological processes in many cell types. Although many 
features of a transcript can contribute to its translation, most control elements are located 
within the untranslated regions (UTRs) of the mRNA. The 5’ UTR has a large influence on 
translation and plays a key role in post-transcriptional gene regulation (Kozak et al., 1987, 
1991 and 1996; Sonenberg et al., 1994; van der Valden et al., 1999; Willis et al., 1999). The 
efficiency of translation initiation is largely governed by the composition and structure of the 5’ 
UTR of the mRNA, which is determined by both its length and its sequence. Stable secondary 
structure and sequence-specific signals and one or two small upstream open reading frames 
(uORFs) within a 5’ UTR can profoundly inhibit protein translation. Most highly expressed 
mRNAs have relatively short (20-100 nucleotides) 5’ UTRs that lack uORFs and extensive 
secondary structures (Kozak et al., 1987). In contrast, mRNAs encoding growth factors, 
transcription factors, oncoproteins, and other regulatory proteins are poorly translated and are 
often long, highly structured 5’ UTRs with multiple upstream ATGs (Kozak et al., 1991, van 
der Valden et al., 1999; Willis et al., 1999). Regulatory proteins interacting with specific 
sequences of the 5’ UTR have also been shown to control the rate of translation (Leibold et 
al., 1988; Rouault et al., 1988). One or more of these mechanisms could operate in the case 
of  Adrenomedullin (AM) mRNA. 
 Adrenomedullin (AM) is a widely distributed multifunctional peptide with critical roles in 
vascular development and function (Kitamura et al., 1993; Sakata et al., 1994; Hinson et al., 
2000; Fernandez-Sauze et al., 2004; Zaho et al., 1998). These functions were discovered 
thanks to many physiological studies and are highlighted in knockout studies in which AM null 
mice die in utero from extreme hydrops fetalis and cardiovascular abnormalities (Caro et al., 
2001; Shindo et al., 2001). AM is highly expressed in a variety of malignant tissues (Hata et 
al., 2000; Rocchi et al., 2001; Miller et al., 1996; Ouafik et al., 2002) and has been 
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 demonstrated to be mitogenic for human lung, breast, colon, glioblastoma and prostate 
cancer cell lines (Rocchi et al., 2001; Miller et al., 1996; Ouafik et al., 2002). Incubation of 
U87 glioblastoma cultures with an AM neutralizing antibody decreased cell proliferation; 
chronic administration of the AM antibody into U87 subcutaneous xenografts dramatically 
decreased tumor size and weight. Similar to the studies for VEGF, the density of blood 
vessels in the AM antibody-treated tumors was also decreased, supporting the roles for AM in 
angiogenesis, vasculogenesis and/or vessel stabilization (Fernandez-Sauze et al., 2004; 
Zaho et al., 1998, Ouafik et al., 2002). In good agreement, Ishikawa et al. (Ishikawa et al., 
2003) demonstrated that the AM antagonist (hAM (22-52)-NH2) inhibited pancreatic cancer 
cell growth in vivo by suppressing tumor vascular development. 
 Many factors closely regulate AM expression including glucocorticoids, androgens, 
hyperthyroidism and hypoxia (Hinson et al., 2000; Murakami et al., 1998; Letizia et al., 1998; 
Pewitt et al., 1999; Garayoa et al., 2000). However, as for many peptidergic systems, the 
complex translational mechanism regulating AM production has not been well studied. 
Accordingly, given the relevance of AM in diverse biological systems, especially the vascular 
and tumor biology (Hinson et al., 2000; Shindo et al., 2001; Ouafik et al., 2002), and the 
important physiological consequences of altered AM expression, the present study evaluated 
the cis-acting sequences in the untranslated region of AM mRNA that might participate in the 
tight regulatory control of AM biosynthesis. Such control could be mediated by the 5’ 
untranslated region (5’ UTR) of AM mRNA, since the 5’ UTRs of several eukaryotic mRNAs 
have recently been shown to influence the rate of their translation. 
 As part of a continuing study on AM function and regulation, we decided to investigate 
the role of the 5’ UTR of the human AM mRNA in gene expression in different cell lines. Here 
we report the presence of stable a stem-loop structure in the 5’ UTR of human AM mRNA 
and provide evidence that this structure plays a role in the regulation of translation of the AM 
message. Reporter assays using a chimeric mRNA that combined luciferase and the 5’ UTR 
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 of AM mRNA demonstrated a dramatic decrease of the reporter activity due to a decreased 
translation, while the deletion of the stem-loop structure localized between nt 31 to 95 from 
the cap site led to the recovery of activity. Using mRNA gel mobility shift assay, we showed 
that a cytoplasmic protein binds specifically to the stem-loop of the AM mRNA 5’ UTR. 
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 Results 
 Using a pair of primers spanning the full length region of the 5’ UTR of AM mRNA for 
RT-PCR, we always observed the presence of two products, one being smaller than 
expected. The size discrepancy between products expected and found was consistently 
approximately ~60 bases. However, RT-PCR products using primers located within the 
coding region of the mRNA were always of the expected size. Sequencing of RT-PCR 
products from isolated RNA revealed that the size discrepancies of the products were, in fact, 
due to the absence of a central region of the 5’ UTR consisting of 65 bases (Figure 1). 
Otherwise, the sequence corresponded to that reported for the 5’ UTR of AM mRNA 
(Kitamura et al. 1993). The location of the missing segment was consistent among different 
RT-PCR amplifications of the same region. Furthermore, sequencing of the PCR fragment 
generated under low concentration of magnesium chloride resulted in the shift of the smaller 
major PCR product to the expected larger product.  
The nucleotide sequences identified in the human AM cDNA are contained in four 
exons in the human gene for preproadrenomedullin (Ishimitsu et al. 1994). The analysis of 
AM gene sequence showed that the 65 bp sequence (nt 31 to 95) is included in exon 1 
coding for nt 1-134 of the 5’ UTR (Figure 1), ruling out the possibility that the 65 bp region is 
an exon and can be deleted by alternative splicing events. Taken together, these data 
suggest that the shortened PCR product is not due to the expression of AM mRNA isoform 
raised by alternative splicing, but rather, due to a secondary structure in the 5’ UTR of AM 
mRNA. To confirm that the missing region was, in fact, present in the mRNA, a cDNA probe 
of 65 bp corresponding to the deleted region was prepared by PCR from pBShAM clone. 
Northern blots using this probe confirmed that the deleted region was indeed present in the 
isolated RNA used for RT-PCR (Figure 2). 
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 Stem-loop structure at the 5’ UTR of AM mRNA – Submission of the 5’ UTR sequence to 
RNA folding software (mfold) predicted that this region could form extensive, stable 
secondary structures through internal base pairing (Figure 3B). Predicted structures of this 
region consistently indicated that ~72% of the bases were paired. This region of secondary 
structure included more than 50% of the 5’ UTR of AM message. 
 To determine whether this 5’ UTR region can in fact fold into higher-order structure, 
the RNA transcript was analyzed by limited RNase digestion. The 5’-end-labeled 71-nt RNA 
(nt 24 to 95) was transcribed and allowed to fold before digestion with double strand-specific 
RNase V1, or single-strand RNase T1, as described in Materials and methods (Figure 3A). 
The enzyme concentrations were empirically determined to produce on average a single 
cleavage hit per molecule. As anticipated, fully denatured transcripts were digested 
completely with RNase T1 (Figure 3A, lane 2). When this RNA was first allowed to fold, 
specific regions of the molecule showed resistance to digestion with nuclease T1 (lane 3), yet 
susceptible to RNase V1 (lane 5) attack, suggesting a double-stranded conformation. From 
these analyses, both weak and strong RNase cleavages were identified on the predicted 
stem loop structure (Figure 3B). Nuclease T1 cleaves RNA 3’ to guanine nucleotides in 
single-stranded regions, and accordingly produced prevalent products corresponding to 
cleavages at two tandem guanine nucleotides (nt 40 and 41) within the predicted loop. As the 
region immediately proximal to the loop (nt 35 to 38) was cleaved by RNase V1, the results 
were congruent with those predicted for a stem loop structure (Figure 3B). The remaining 
segments (nt 6 to 20 and nt 57 to 71) were sensitive to RNase V1 double-stranded RNA 
digestion indicating a long stretch of nucleotide pairing to form the base of the stem. 
 
Regulation of AM mRNA translation by 5’ UTR using reporter assay - A prominent stem loop 
structure in the 5’ UTR of the AM mRNA can introduce important RNA-based control 
elements for posttranscriptional regulation of AM expression. Accordingly, the functional 
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 consequences of the 5’ UTR on AM translational efficiency was evaluated using luciferase-
based reporter assays and the results agreed with that hypothesis. Several SV40 - firefly 
luciferase expression constructs were prepared as shown in Figure 4A. The luciferase 
reporter gene combined with different sequences of 5’ UTR of the AM mRNA was placed 
under the control of the simian virus 40 promoter (Figure 4A). The expression level of the 
reporter gene was quantified by assaying luciferase luminescence. The amount of firefly 
luciferase expression 24 h after transfection was expressed as a function of Renilla luciferase 
luminescence (20ng/transfection) to normalize transfection efficiency. Control cells 
transformed with vector alone showed high luciferase enzymatic activity, whereas the 
presence of the full-length AM mRNA 5’ UTR resulted in a clear decrease of luciferase 
activity in all the cell lines used. The marked decrease (50% to 70%) in translational efficiency 
demonstrates that the response was independent of cell type (Figure 4B). In contrast, the 
enzymatic activity was recovered when the luciferase reporter gene with the truncated AM 
mRNA 5’ UTR∆nt 31-95 was used to eliminate the secondary structure site (Figure 4B).  
 To ensure that the decrease in firefly luciferase activity reflected decreased translation 
rather than altered mRNA stability, transcription or RNA nuclear retention, total RNA was also 
isolated from parallel transfected cells and subjected to slot blot analyses using firefly and 
Renilla luciferase probes. Normalized to Renilla luciferase mRNA levels, the resulting 
analyses revealed that firefly luciferase mRNA expression was comparable between 
differents luciferase reporter constructs (Figure 4C). Accordingly, the differences in luciferase 
activity among the different transfectants were not due to changes in firefly luciferase 
expression levels, from mRNA stability or transfection efficiency, but most likely reflected 
altered translational efficiency. 
 
Characterization of AM mRNA binding protein (AM mRNA-BP) – To determine whether 
cytoplasmic extracts might contain a protein(s) that binds to the AM mRNA, band-shift assays 
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 were performed. Gel migration shift assays using riboprobe corresponding to the AM full 
length cDNA (AM FL) demonstrated the presence of a protein(s) in cytoplasmic extracts of 
U87 cells able to bind to AM mRNA (Figure 5). To estimate the mass of the AM mRNA 
binding protein(s) and characterize the composition of the RNA-protein complex, UV light was 
used to covalently cross-link radiolabeled AM RNA to proteins of U87 cytoplasmic extracts 
(Wilusz et al., 1988). Figure 5 illustrates the apparent migration of the RNA-protein complex 
on SDS-polyacrylamide gel (Laemmli, 1970). After the radiolabeled transcripts were 
incubated with cytoplasmic extracts and irradiated, two samples were retained for RNA band-
shift analysis (Figure 5A, lanes 2 and 3), and the remaining samples were boiled in Laemmli 
buffer (Laemmli, 1970) (Figure 5A; lanes 4 and 5). Under these conditions, only a single 
stable complex migrating with a molecular mass of approximately 14 kDa was observed 
(Figure 5A), providing evidence for the existence of a single subunit in the AM mRNA-protein 
complex. No complex formation was observed when nuclear extracts were used (Figure 5A, 
lane 6), suggesting that the binding elements were derived entirely from the cytoplasm. In the 
absence of lysate, RNase T1 cleaved radiolabeled AM RNA, and no complex was observed 
(lane 1). No bands were detected in the absence of UV treatment (data not shown).  
Incubation of 32P-labeled AM transcripts with 30 µg cytoplasmic proteins, in the presence of 
1- to 100-fold excess of unlabeled AM RNA in competition assays, completely blocked 
radiolabeled transcript-protein complex formation (Figure 5B; lanes 4 to 6). By contrast, the 
intensity of the band was not diminished by the addition of equal amounts of the unlabeled 
nonspecific hPAM RNA competitor (Figure 5B; lanes 7 to 9), suggesting that the U87 
cytoplasmic protein(s) bound to the AM mRNA specifically. 
 To establish that the binding factor was indeed proteinaceous, the U87 cytoplasmic 
extracts were digested with proteinase K (100 µg/ml) or pronase (100 µg/ml) at 37oC for 15 
min prior to RNA probe incubation. Digestion with proteases completely abolished the shifted 
band (Figure 4C, compare lane 1 with lanes 2 and 3).  Heating the cytoplasmic extracts at 
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 100oC for 10 min abolished complex formation (Figure 5C, lane 5). Denaturation of the 
cytoplasmic lysates with 0.02% SDS was also sufficient to suppress the RNA-protein complex 
formation (Figure 5C, lane 6). As the data demonstrated that the cytosolic material was heat- 
and protease-sensitive, the factor was termed AM mRNA-binding protein (AM mRNA-BP). 
 To map the binding region of AM mRNA to which binds AM mRNA-BP, additional 
band-shift analyses were performed using deletion variants of the AM transcripts. AM 
transcripts (AM1 to AM3) were transcribed in vitro as described in Materials and methods and 
assessed for their capacity to bind AM mRNA-BP using U87 cytoplasmic extracts. While the 
5’-AM transcript (AM1) demonstrated the same capacity to bind AM mRNA-BP as the AM FL 
(Figure 5D), no binding was seen with riboprobes corresponding to either the coding region 
(AM2), or the 3’ UTR (AM3) of AM mRNA. These data demonstrate that AM mRNA-BP 
interacts with a region common to full length AM mRNA and AM1, corresponding to the 5’ 
UTR region of the AM mRNA. To refine the protein-binding site within the 150 nt of the 5’ 
UTR, transcripts with 5’ UTR truncations (AM4 to AM9) were radiolabeled and also tested for 
their abilities to bind AM mRNA-BP (Figure 6). From these studies, AM mRNA-BP binding 
was restricted to a site within +31 to +95 nt upstream of translation initiation site; very low 
binding was observed using transcripts (AM5, AM6 and AM8) that overlapped the identified 
region. Interestingly, no binding was seen with riboprobe of the 5’ UTR lacking the region of 
secondary structure (AM9), suggesting that the region of secondary structure in the 5’ UTR 
was required for binding of this cytosolic factor.  
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 Discussion 
 This report reveals some novel aspects of posttranscriptional regulation of AM gene 
expression in different cell lines. We have investigated the role of the stem-loop structure 
found at the 5’-end of AM mRNA. Our data, using primers spanning the 5’ UTR of AM mRNA, 
demonstrated that, in addition to the RT-PCR product with the expected size, a product 
shorter than expected by approximately ~65 bases was consistently observed. The sequence 
of this product clearly demonstrated that the smaller size was due to the deletion of a central 
region of the 5’ UTR of the AM message. This deleted region contained 65 bases (nt 31 to 
95) and was capable of forming stable secondary structures with ~70% of the bases paired. 
Northern blotting with probes specific to the missing region of the 5’ UTR showed that the 
amplification of the smaller RT-PCR product was not due to the absence of the 65 bp region 
in the RNA used in the reaction. Furthermore, the 65 bp sequence is part of exon 1 sequence 
in AM gene and unlikely to be deleted by alternative splicing events. Mechanisms accounting 
for the ability of a polymerase copying a template to skip a region and then resume faithful 
transcription of the remainder of the sequence have been proposed by others to explain 
internal deletions occuring during DNA synthesis by DNA polymerase (Glickman et al., 1984; 
Cariello et al., 1991; Canceill et al., 1996; Odelberg et al., 1995). In all cases, these models 
require that the deleted sequence contains a region of stable secondary structure. Our 
observations were therefore consistent with the presence of a secondary structure in the 5’ 
UTR of AM mRNA across which the polymerase or reverse transcriptase could skip in the 
PCR or RT-PCR reactions, continuing the replication of the sequence beyond the site of 
secondary structure. The role of secondary structure in this deletion event is supported by the 
fact that shortened PCR products were promoted by higher magnesium concentrations, since 
magnesium has been reported to promote base pairing into higher order structures (Laing et 
al., 1994). 
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  Enzymatic probing has revealed a higher-order structure for the stem-loop in the 5’ 
UTR of AM mRNA. Furthermore, the ability of RNase T1 to digest completely a riboprobe 
corresponding to the coding region (AM2) and the 3’ UTR (AM3) of AM mRNA confirmed that 
this resistance of the 5’ UTR to digestion was not a general characteristic of all regions of the 
AM message. Stem-loop structure negatively regulates expression of reporter mRNAs at the 
translational level, suggesting that the 5’ stem-loop is sufficiently stable to prevent translation 
once ribosome scanning has started (Kozak, 1991). Using our constructs in transient 
transfections into U87, PC3, MCF7 and HTC116 cells, we demonstrated a three to six fold 
inhibition of the luciferase protein expression. The analysis of steady-state levels of mRNAs 
showed no destabilization of the mRNA containing the stem-loop compared to mRNA with 
deleted stem-loop. The stem-loop structure appears to be necessary to modulate the AM 
mRNA translation. These data provide good evidence for mRNA structure that regulate the 
expression of AM peptide, although alterations in AM protein stability could not be excluded. 
Finally, in cell extracts, we could demonstrate binding of a protein factor to the 5’ stem-loop, 
which might be involved in the downregulation of translation. 
 There is a short, but growing, list of genes containing RNA cis-elements that modulate 
translation: the transcript for FMR protein (Fragile X mental retardation protein) encodes 5’ 
UTR secondary structure which is sufficiently stable to suppress downstream FMR protein 
translation (Feng et al., 1995), tissue-specific regulation of fibroblast growth factor 2 
translation appears to be dependent on its 5’ UTR (Creancier et al., 2000), 15-lipoxygenase, 
fibronectin, lipoprotein lipase, folate receptor-α, interferon-γ, transforming growth factor-β1, m-
numb, and neural nitric-oxide synthase (nNOS), among others (Galy et al., 2001; 
Rabganatham et al., 2000; Ben-Asouli et al., 2002; Ostareck et al., 1997; Imai et al., 2001; 
morrisey et al., 2001). Similarly, vascular endothelial growth factor regulation by hypoxia 
(Stein et al., 1998) and platelet-derived growth factor 2/c-sis expression that occurs during 
differentiation (Bernstein et al., 1997) are regulated in this way as well. 
 12
H
AL author m
anuscript    inserm
-00151027, version 1
  Evidence from gel mobility shift assays clearly demonstrates specific binding of a 
cytosolic protein(s) to riboprobes containing the 5’ UTR of AM mRNA. Such binding is not 
seen to riboprobes corresponding to other areas of the AM mRNA and appears to require the 
presence of the region of secondary structure because a riboprobe containing the 5’ UTR 
sequence but lacking the deleted region showed no binding. The RNA-protein binding seems 
specific to the AM 5’ UTR sequences since only an excess of homologous unlabeled AM 5’ 
UTR transcripts blocked RNA-protein complex assembly; unrelated nonspecific transcripts by 
contrast were unable to compete for protein binding. The proteinacious character of the 
binding element was verified as protease digestion or heat denaturation of the cell extracts 
abrogated complex formation, and UV crosslinking studies demonstrated that the binding 
protein had a mass of approximately 14 kDa. Furthermore, as the AM mRNA-BP was found 
only in cytosolic and not nuclear extracts, the binding protein was unlikely to participate in 
pre-AM mRNA splicing or nuclear shuttling.  
 Secondary structures in the 5’ UTR of several mRNAs have been shown to repress 
translation of those mRNAs, presumably by stalling the “scanning” of ribosomal initiation 
complexes (Kozak, 1989). Studies involving insertion of synthetic oligonucleotides that form 
stable hairpin structures within the 5’ UTR of preproinsulin (Kozak, 1986) and thymidine 
kinase (Pelletier, 1987) mRNAs and subsequent expression in COS cells demonstrated that 
excessive secondary structure in the 5’ UTR represses translation. Furthermore, structures 
with predicted free energies greater than –50 kcal/mol were able to inhibit translation by 85-
90%, whereas structures with predicted weaker secondary structure were readily translated 
(Kozak, 1986). We cannot exclude that the interaction of AM mRNA-BP with the stem-loop 
structure could be responsible of a steric hindrance impeding the fixation of the initiation 
complex and/or could better stabilizes the stem-loop structure to be higher than –30 kcal/mol 
and is thus sufficient to block scanning ribosomes to reach the start codon. Recently, it was 
demonstrated that binding of IRP-1 to the IRE located close to the cap structure of mRNAs 
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 represses translation by precluding the recruitement and formation of the 43S preinitiation 
complex (Paraskeva et al.,  1999). 
 
 In summary, this report reveals some novel aspects of posttranscriptional regulation of 
AM gene expression in various cell types and demonstrates the ability of the 5’ UTR of AM 
mRNA to repress AM mRNA translation. However, our study poses several questions related 
to mechanisms of AM mRNA-BP actions in translation inhibition and the regulation of AM 
mRNA-BP itself. The 14 kDa AM mRNA-BP may interfere with ribosome binding and/or 
scanning to impede efficient translation. The ongoing purification and identification of the AM 
mRNA-BP will greatly contribute to our understanding of AM gene regulation and would 
permit examinations of its sites of actions and address whether initiation or downstream AM 
translational events are inhibited upon stem loop-AM mRNA-BP complex formation. This 
work also raises the question as to how this translational repression is overcome by inducing 
stimuli.
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 Materials and methods 
 
Cell culture - All the cell lines were obtained from American Type Culture Collection 
(Rockville, MD, USA). Human glioblastoma cell lines U87 and U138 were maintained in 
minimum essential medium (MEM); MCF-7 breast cancer cell line was maintained in 
DMEM/F-12 medium, and PC-3 prostate cancer cell line was maintained in RPMI 1640 
medium. Among colon cancer cell lines, HCT 116 was cultured in Dulbecco’s modified 
Eagle’s Medium (DMEM). All of the culture media were supplemented with 10% fetal bovine 
serum (Invitrogen Life Technologies, Cergy Pontoise, France), penicillin (50 U/ml), 
streptomycin (50 µg/ml), glutamine (1 mg/ml), and the necessary associated factors for each 
cell line. The cells were cultured at 37°C under humidified 95% air/5% CO2 atmosphere. The 
medium was replaced every two days. 
 
Northern blot Analysis - Total RNA was prepared from U87 and U138 cell lines using the acid 
guanidinium isothiocyanate/phenol/chloroform procedure (Chomczynski et al. 1987). Northern 
blot analysis was performed essentially as described previously (El Meskini et al. 1997). 
Briefly, total RNA (10 µg) was resolved on 1% agarose-formaldehyde denaturing gel. The 
denatured RNAs were transferred to Hybond-N membranes (Amersham Biosciences, 
France) by capillary action in 10X SSC [1.5 M NaCl, 0.15 M sodium citrate (pH 7.0)], cross-
linked by UV irradiation and hybidized to [α−32P]-labeled human cDNA probes corresponding 
to the region of the AM 5’ UTR nt 31 to 95 and 1.2-kb AM cDNA (Kitamura et al. 1993), 
respectively. Filters were prehybridized, hybridized, and washed as described previously (El 
Meskini et al. 1997).  
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 Enzymatic mapping of the RNA structure - Radiolabeled 5’ UTR stem-loop RNA was 
synthesized by in vitro transcription end-labeling with 30 µCi of [γ-32P]GTP using T7 RNA 
polymerase (Invitrogen Life Technologies). The precipitated labeled RNA was washed and 
dissolved at 5 x 104 cpm RNA/20 µl in 20 mM HEPES RNA renaturing buffer, pH 7.6, 
containing 200 mM NaCl, 1 mM DTT, 10 mM MgCl2. The RNA was heated to 85°C for 2 min, 
renatured by slow cooling to room temperature for 30 min, and placed on ice. Transfer RNA 
(0.15 mg/ml) was added to the tubes and the RNA aliquoted at 2 µl/ tube for RNase digestion. 
Twenty thousand counts per minute of the RNA in a total volume of 20 µl was digested with 
double-strand-specific RNase cobra venom nuclease V1 (RNase V1; 2.5 x 10-6 U/ml; Ambion) 
for 1 min at RT, or a single-strand-specific RNase T1 (1.5 x 10-4; 6 x 10-5; or 2.5 x 10-6µg/ml; 
Roche Applied Science) for 1 min at RT. After the indicated times, the reactions were stopped 
by extraction with phenol-chloroform and the RNAs were precipitated with ethanol. As a 
control, the RNA was denatured and digested with 2.5 x 10-2 µg/ml of RNase T1 for 10 min at 
RT. All samples were analyzed on 8% denaturing polyacrylamide gels. Nucleotide 
assignments of the cleavage sites were made relative to the position of two G’s in the top 
loop as they were resolved in the RNase T1 lane.  
 
Preparation of luciferase constructs – The full-length human AM cDNA (1490 bp) was 
obtained by polymerase chain reaction (PCR) synthesis from total RNA prepared from U87 
glioblastoma cell line and subcloned into Srf I site of the PCR-Script SK+ plasmid (Stratagene 
Europe). The resultant plasmid, containing hAM cDNA in the sense orientation under the 
control of the T3 polymerase promoter, was sequenced for fidelity and designated pBS-hAM. 
A cDNA containing the full length 5’ UTR of AM was produced by PCR using pBS-hAM as a 
template. A cDNA containing the 5’ UTR of AM, but lacking the region of secondary structure, 
 16
H
AL author m
anuscript    inserm
-00151027, version 1
 was produced by RT-PCR using total RNA prepared from U87 cells and previously reverse 
transcribed to cDNA. The upper primer AM5’sense(a) (AM cDNA1-20; 5’-CGCCATGGCTTGGT 
GACACTGGATAGAA-3’) was paired with lower primer AM5’ antisense (b) (AM cDNA150-130; 
5’-CGCCATGGAGACCCTGCTAAGAGTGA-3’) to produce 150 bp and 85 bp fragments, 
respectively. The PCRs were carried out for 35 cycles, with each cycle consisting of 
denaturation (94°C for 30 s), annealing (65°C for 30 s), and extension (72°C for 30 s) using 
Taq DNA polymerase (invitrogen life Technologies). The underlined sequences correspond to 
Nco I sites included for subsequent subcloning. The products were inserted into TOPO vector 
(Invitrogen Life Technologies) for sequencing to verify deletion and recloned into the Nco I 
site of the PGL3 vector (Promega, Lyon, France) to generate AM 5’ UTR1-150/Luc (construct 
b) and 5’ UTR∆31-95 /Luc (construct c), respectively. All constructs were verified by direct 
sequencing.  
 
Luciferase reporter assay and Slot blot analysis of reporter mRNA - A dual luciferase reporter 
assay system was employed. U87 Cells (2 x 105 cells/ml) were transfected with a mixture of 
firefly luciferase reporter vector (200 ng), Renilla luciferase control vector pRL-TK (20 ng, 
Promega, Lyon, France), and pBS SK+ vector (780 ng, 1 µg vector total), using the Fugene 6 
transfection reagent (Roche Applied Science). After 24 h, the cells were lysed with assay 
buffer (Promega) and both firefly (Photinus pyralis) (reporter) and sea pansy (Renilla 
reniformis) (control) luciferase activities were measured sequentially using the Dual-
Luciferase Assay Reporter System (Promega) with a Berthold lumat LB9507 luminometer. 
The ratio of reporter luciferase activity in relative light units was divided by the control Renilla 
luciferase activity to give a normalized reporter luciferase value. 
For RNA analysis, U87 cells were transfected as above for total RNA extraction using the 
acid guanidinium isothiocyanate/phenol/chloroform procedure (Chomczynski et al., 1987). 
Slot blot analysis was performed essentially as described previously (El Meskini et al. 1997) 
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 to assess reporter luciferase mRNA and control Renilla luciferase mRNA expression. Briefly, 
total RNA (10 µg) was denatured by heating at 65°C for 15 min in 2.2 M formaldehyde, 
6XSSC (1X SSC: 0.15 M NaCL, 0.015 M sodium citrate, pH 7.0) and cooled on ice before 
applying on a  Hybond-N membrane (Amersham Biosciences) by using the Schleicher & 
Schuell (Keene, NH) Minifold II Slot-Blotter. After 1 x 106 cpm of the 32P-labeled probe/1 ml of 
hybridization solution was added, filters were hybridized and washed as described (Brenet et 
al., 2005). The expression levels of luciferase/AM-5’ UTR chimeric mRNA versus those of 
control Renilla mRNA in U87 cells were determined from the autoradiographic densitometry 
using NIH Image 1.54 software (National Institutes of Health, Bethesda, MD). 
 
Cell extract preparation - Cells from confluent cultures (75-cm2 flasks) were collected by 
centrifugation, washed once with Ca2+- and Mg2+-free phosphate buffered saline and 
homogenized on ice in lysis buffer A containing 10 mM HEPES (pH 7.5), 40 mM KCl, 3 mM 
MgCl2, 1 mM dithiothreitol (DTT), 0.2% Nonidet P40, 5% glycerol, 10 µg/ml leupeptin and 0.5 
mM phenylmethylsulfonylfluoride (PMSF), using a teflon pestle. The homogenate was 
centrifuged at 800 x g for 10 min at 4°C to yield a P1 pellet containing nuclei and a S1 
supernatant fraction. The S1 fraction was centrifuged at 100,000 x g at 4°C for 30 min 
(Beckman Ti50 rotor) and the resulting supernatant retained as cytosol extract and stored at 
–70°C. The P1 pellet was resuspended in 1 ml TKM buffer containing 0.25 M sucrose buffer 
(TKM; 50 mM Tris-HCl, pH 7.5, with 25 mM KCl, 5 mM MgCl2, and inhibitors). The sample 
sucrose concentration was adjusted to approximately at 1.62 M by addition of 2 ml TKM 
buffer containing 2.3 M sucrose buffer; this material was layered onto 1 ml TKM 2.3 M 
sucrose buffer and centrifuged at 100,000 x g for 30 min at 4°C (Beckman SW60 rotor). The 
resulting nuclei pellet was resuspended in 100 µl of buffer A, homogenized and centrifuged at 
12,000 x g for 10 min and nuclei protein extracts were frozen rapidly and stored at –70°C. 
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 Sample protein concentrations were determined using the bicinchoninic acid protein assay 
reagent (Pierce chemical Co., Interchim, Paris). 
 
Plasmid constructions - The pBS-hAM plasmid was linearized with Kpn I to allow generation 
of the full-length 1400 nt hAM transcript (AM FL). PCR was used to generate 5’ UTR (AM1; 
bp 1-150), open reading frame sequence (AM2; bp 157-714), and 3’ UTR (AM3; bp 715-
1400) truncated hAM cDNAs (see Figure 5D). To generate the described constructs the 
following primers were used. A 5’ primer that included a T7 RNA polymerase promoter 
sequence, which is underlined: (AM cDNA1-20; 5’-AATACGACTCACTATAGGGCTTGGTGAC 
ACTGGATAGAA) was paired with 3’ primer (AM cDNA150-130; 5’-AGACCCTGCTAAGAGTGA-
3’) to generate AM1. The 5’-AM cDNA166-186; 5’-AATACGACTCACTATAGGGATGAAGCTGG 
TTTCCGTCGC-3’ primer was paired with 3’ primer (AM cDNA724-700; 5’-CTAAAGAAAGTGGG 
GAGCAC-3’) to generate AM2. For 3’ UTR hAM cDNA, the sense primer (AM cDNA725-745; 5’-
AATACGACTCACTATAGGGGATTTAGGCGCCCATGGTAC-3’) was paired with the 
antisense primer (AM cDNA1400-1380; 5’-CCTTCTTCCACACAGGAGGT-3’) to generate AM3 
(Figure 5D). The amplified DNA fragments were excised after electrophoresis in low-melting-
point agarose, precipitated and used for in vitro transcription.  
 
Preparation of RNA transcripts - The in vitro transcription reaction mixture (20 µl), containing 
40 mM Tris-HCl (pH 7.9), 6 mM MgCl2, 10 mM NaCl, 2 mM spermidine, 20 µM DTT, 5 mM 
each rATP, rGTP, and rCTP (Invitrogen Life Technologies), 10 µM UTP, [α-32P]UTP (50 µCi, 
3,000 Ci/mmol; Amersham Biosciences), 20 U of T7 RNA polymerase (invitrogen Life 
Technologies), 1 µg DNA template, and 20 U RNasin (Promega), was incubated at 37oC for 1 
h. After template digestion, the radiolabeled RNA was precipitated and dissolved in 10 µl 
loading buffer (7M urea and 0.025% bromophenol blue) for electrophoresis on an 6% 
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 polyacrylamide gel containing 7M urea. After autoradiography, the full-length radiolabeled 
RNA transcripts were identified and eluted from excised gel slices by incubation in 0.5 M 
ammonium acetate buffer, containing 1 mM EDTA, 1 mM DTT, 10 µg tRNA, and 5 U RNasin, 
overnight at 37oC. The radiolabeled probes were precipitated, reconstituted in water at a 
specific activity of 5 x 107 - 5 x 109 cpm/µg RNA, and stored at –80°C. Unlabeled RNA 
transcripts were synthesized as described above with 5 mM rUTP, processed, quantitated by 
absorbance at 260 nm, and stored at –80°C until use. 
 
Gel mobility shift assay for RNA-protein interactions - RNA mobility shift assays were 
performed as described previously (Fraboulet et al., 1998; Brenet et al., 2005). Unless 
otherwise indicated, cytoplasmic extracts (30 µg) were incubated with radiolabeled transcript 
(2-3 x 105 cpm) in 20 µl of 15 mM HEPES (pH 8.0), containing 5 µg yeast tRNA, 10 mM KCl, 
10% glycerol, and 1 mM DTT, for 10 min at 30oC prior to the addition of 0.1 mg/ml RNase A. 
For competitions studies, unlabeled AM RNAs were added 15 min before radiolabeled RNA 
to protein fraction in the buffer described above. Following a 20 min incubation with RNase A 
at 37°C, 4 µl of 6X native gel loading buffer (30% glycerol, 0.025% bromophenol blue and 
0.025% xylene cyanol) were added, and the RNA-protein complexes were resolved on a 5% 
polyacrylamide gel. After RNase A digestion, UV cross-linking studies were performed by 
exposing the reaction mixtures on ice for 10 min to 254 nm UV light in a Stratalinker 
(Stratagene Europe) on the automatic settings. Subsequently, the cross-linked samples were 
either resolved directly on 10% polyacrylamide-SDS gels or previously boiled for 5 min in 1X 
SDS sample buffer. Gels were dried and exposed to X-ray film for 10 to 15h with intensifying 
screen at –70°C. All the experiments were performed at least three times. 
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 RNA folding analysis - Mfold RNA/DNA folding program available through Rensselaer 
Polytechnic Institute webserver (bioinfo.math.rpi.edu/mfold/rna/) was used to predict AM 5’ 
UTR secondary structure (Zuker et al., 2003). 
 
Statistical analyses - Transfection and luciferase mRNA decay data are shown as mean ± 
SEM. Statistical analyses were performed using the one-way ANOVA followed by Fisher’s 
protected least significant difference test (Statview 512, Brain Power Inc., Calabasas, CA).  
Statistical significance was assessed at P < 0.05.  
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 Figures legends 
 
Figure 1. Comparison of the reported sequence with the sequences of the RT-PCR products. 
Only 5’ UTR with sequence of coding region and exon 1 (nt 1 to 134) sequence of preproAM gene 
are shown. Bases are numbered as in Kitamura et al. (1993). The RT-PCR products were 
synthesized using primers a and b (see Materials and methods for primer sequences and sites), 
and total RNA isolated from U87 cells. PCR product was generated using primers a and b with 
pBS-hAM as the cDNA template that contains the entire 5’ UTR of human AM mRNA. Upper and 
lower case letters indicate sequence of 5’ UTR or exon 1, and intron 1 (Ishimitsu, et al. 1994), 
respectively. Translation signals are shown in bold. 
 
Figure 2. Presence of the deleted sequence in total RNA preparations used for RT-PCR. 
Total RNA (10 µg) isolated from U87 and U138 cell lines were separated by 1% agarose-
formaldehyde denaturing gel electrophoresis, transferred to Hybond-N membranes, and probed 
first (lanes 1 and 2) with a cDNA probe (nt 31 to 95) corresponding to the region of the AM 5’ UTR 
deleted in the RT-PCR reaction. The membrane was then stripped until no radioactivity could be 
detected and was subsequently reprobed with a human AM cDNA (nt 200 to 1200) (lanes 3 and 4). 
Migrations positions of 28 and 18 S rRNAs, as determined using ethidium bromide staining, are 
indicated for reference. 
 
Figure 3.  AM 5’ stem-loop structure. A, enzymatic probing of the synthetic 5’ stem loop RNA.  
5’-end-labeled human AM 5’ RNA with the predicted stem loop sequence was subjected to 
digestion with RNase T1 under denaturing conditions (lane 2), or in its folded conformation (lanes 
3-5) or with RNase V1 (lane 6) in its folded conformation. Cleavages after G nucleotides is 
indicated by open arrows. The cleavage products were separated on an 8% polyacrylamide 
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 sequencing gel. B, Sequence of the human AM 5’ stem-loop; nt 24 to 95 from the 5’-end are 
shown. Cleavages sites of RNase T1 are indicated by arrows. 
 
Figure 4. Effect of the AM 5’ UTR on the translational efficiency of chimeric RNA. A, 
Schematic representation of luciferase reporter constructs containing the 5’ UTR of AM (b), the AM 
5’ UTR∆nt 31-95 (c), and pLuc vector (a). All the constructs were under the simian virus 40 (SV40) 
promoter.  B, Luciferase reporter assay. U87, PC3, MCF7, and HTC116 cells were transiently 
cotransfected with the indicated luciferase reporter constructs and the Renilla reporter construct 
(pRL-TK; see Materials and methods) for 24 h. The results are presented as ratios of firefly 
luciferase reporter activity over sea pansy (Renilla) luciferase activity, the latter being used as a 
control. Each bar represents the mean ± SEM; asterisks indicate that the values are significantly 
different between a, c, and b (**, p < 0.008 ; ***, p < 0.0001). Similar data were obtained from three 
independent experiments. C, U87 cells were cotransfected with the indicated luciferase reporter 
constructs and the Renilla reporter construct. Total RNAs were prepared 24 h later. Slot blots 
containing 10 µg of each total RNA were hybridized to probe corresponding to firefly luciferase 
cDNA and exposed to X-ray film at –70°C with an intensifying screen. The blot was stripped and 
reprobed with 32P-labeled Renilla luciferase probe to normalize data for quantification. Each bar 
represents the mean ± SEM of three independent experiments. The same results have been 
obtained with PC3, MCF7, and HTC 116 cells (not schown). 
 
Figure 5. Formation of specific RNA-protein(s) complexes between AM mRNA and U87 
cytoplasmic extracts. A, identification of a single cytosolic protein interacting with labeled hAM 
RNA. 32P-labeled riboprobe hAM (2 x 105 cpm) was incubated at 30oC with U87 cytoplasmic 
extracts (30 µg) for 10 min before RNase A digestion. After incubation with RNase A, 32P-labeled 
RNA-protein complexes were UV cross-linked as described in Materials and methods. The binding 
 28
H
AL author m
anuscript    inserm
-00151027, version 1
 mixtures were analyzed by electrophoresis on a SDS-10% PAGE. No RNA-protein complex was 
observed in the absence of protein extracts (lane 1). Band shift assays, performed in the presence 
of protein extracts without (lanes 2 and 3) or with (lanes 4 and 5) SDS sample buffer treatment, 
showed a 14 kDa protein complex formation. No RNA-protein complex was observed in the 
presence of nuclear extracts (lane 6).  B, no RNA-protein complex formation can be observed 
when protein extracts were omitted (lane 1). Labeled RNA was incubated with protein extracts 
alone (lanes 2 and 3) or in the presence of increasing amounts of either unlabeled hAM transcript 
(specific competitor; 1-, 10-, and 100-fold molar excesses in lanes 4, 5, and 6, respectively) or 
unlabeled human Peptidylglycine α-amidating monooxygenase (hPAM) transcript (nonspecific 
competitor; lanes 7, 8, and 9). C, a complex at 14 kDa was observed using samples without 
proteases treatment (lanes 1 and 4). Treatment of protein extracts with proteinase K (PK; 100 
µg/ml) or pronase (Pro; 100 µg/ml) at 37 oC for 15 min prior the addition to RNA-binding reaction 
mixtures containing 32P-labeled RNA abolished complex formation (lanes 2 and 3). Heating the 
protein extracts for 10 min at 100 oC abolished the binding activity to form complex with labeled 
RNA (lane 5). Treatment of protein extracts with 0.02% SDS also prevented the complex formation 
(lane 6). D, Summary of RNA band shift analysis performed with deletion variants of the AM cDNA. 
Radiolabeled RNA probes containing the indicated regions of the AM cDNA were prepared as 
described in Materials and methods. Band shift assays were performed with 30 µg of U87 
cytoplasmic extracts and each RNA. Each RNA probe either showed maximum binding (++), as 
illustrated in A for the full length AM riboprobe, or no binding (--). 
 
Figure 6. AM mRNA core binding site maps within the 65-nt segment of nt 31-95 of the AM 5’ 
UTR RNA. A, summary of deletion analysis of the AM 5’ UTR band shift complex. The open bar is 
a representation of a complete 155-nt AM 5’ UTR. RNA probes were prepared as described in 
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 Materials and methods. The first and last nucleotides of each transcript are indicated. B, UV cross-
linking was performed with U87 cytoplasmic extracts (30 µg) and each described RNA probe. 
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